Page last updated: 2024-11-06

timefurone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID72161
CHEMBL ID297550
SCHEMBL ID634935
MeSH IDM0135504

Synonyms (24)

Synonym
4,9-dimethoxy-7-((methylthio)methyl)-5h-furo(3,2-g)(1)benzopyran-5-one
76301-19-4
D06151
timefurone (usan/inn)
timefurone
CHEMBL297550
u-56321
u-56,321
4,9-dimethoxy-7-(methylsulfanylmethyl)furo[3,2-g]chromen-5-one
timefurone [usan:inn]
0415629f6c ,
timefurona [spanish]
5h-furo(3,2-g)(1)benzopyran-5-one, 4,9-dimethoxy-7-((methylthio)methyl)-
timefuronum
timefurona
unii-0415629f6c
timefuronum [latin]
timefurone [usan]
timefurone [inn]
4,9-dimethoxy-7-[(methylthio)methyl]-5h-furo[3,2-g][1]benzopyran-5-one
5h-furo[3,2-g][1]benzopyran-5-one,4,9-dimethoxy-7-[(methylthio)methyl]-
SCHEMBL634935
DTXSID40227178
Q27247598

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In normal male rats, a dose-response study with timefurone (3, 10, 30, 50 and 100 mg/kg/day) was conducted for 7 days."( Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male SEA Japanese quail and rats.
Day, CE; Gammill, RB; Schurr, PE; Stevens, TJ, 1985
)
0.88
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID203649Serum lipoprotein (VLDL+LDL) cholesterol alteration by the compound at 50 mg/kg/day dose in normocholesterolemic Male S.E.A. Japanese quail with 5-7 weeks of age1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones.
AID82013Serum high density lipoprotein (HDL) cholesterol alteration by the compound at 50 mg/kg/day dose in normocholesterolemic Male S.E.A. Japanese quail with 5-7 weeks of age1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones.
AID203650Total Serum HDL cholesterol alteration by the compound at 50 mg/kg/day dose in normocholesterolemic Male S.E.A. Japanese quail with 5-7 weeks of age1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (11.11%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]